February 20, 2018 2018 ISCTM Distinguished Poster Award Winner: “Global Regulatory Agencies Support Dopamine Transporter Neuroimaging in Clinical Trials Targeting Parkinson’s disease”
February 12, 2018 Tucson-based Critical Path Institute emerging as top drug-research organization President and CEO Dr. Martha Brumfield was recently interviewed by the Arizona Daily Star for a profile on C-Path published Februa
February 5, 2018 Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Wor
February 1, 2018 Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
January 22, 2018 Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort
January 22, 2018 Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker Tucson, AZ — January 22, 2018 — Critical Path Institute (C-Path) announced today that the European Medicines Agency (E
January 17, 2018 C-Path welcomes Kay Holcombe to its Board of Directors January 17, 2018 TUCSON, Ariz., January 17, 2018 — The Critical Path Institute (C-Path) is pleased to welcome Kay Holcombe to i
January 9, 2018 Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis
January 9, 2018 Training on the use of technology to collect patient-reported outcome data electronically in clinical trials: best practice recommendations from the ePRO Consortium Ly, JJ, Crescioni, M, Eremenco, S, Bodart, S, Donoso, M, Butler, AJ, et al. Training on the use of technology to collect patient-r
January 6, 2018 Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium